Instituto de Neurociencias y Departamento de Biología Celular, Fisiología e Inmunología, Facultad de Biociencias, Universitat Autònoma de Barcelona, Barcelona, Spain.
Int J Biol Sci. 2012;8(9):1254-66. doi: 10.7150/ijbs.4679. Epub 2012 Oct 25.
Interleukin-6 (IL-6) is a cytokine originally identified almost 30 years ago as a B-cell differentiation factor, capable of inducing the maturation of B cells into antibody-producing cells. As with many other cytokines, it was soon realized that IL-6 was not a factor only involved in the immune response, but with many critical roles in major physiological systems including the nervous system. IL-6 is now known to participate in neurogenesis (influencing both neurons and glial cells), and in the response of mature neurons and glial cells in normal conditions and following a wide arrange of injury models. In many respects, IL-6 behaves in a neurotrophin-like fashion, and seemingly makes understandable why the cytokine family that it belongs to is known as neuropoietins. Its expression is affected in several of the main brain diseases, and animal models strongly suggest that IL-6 could have a role in the observed neuropathology and that therefore it is a clear target of strategic therapies.
白细胞介素 6(IL-6)是一种细胞因子,大约 30 年前被首次鉴定为 B 细胞分化因子,能够诱导 B 细胞成熟为产生抗体的细胞。和许多其他细胞因子一样,人们很快意识到,IL-6 不仅是一种仅参与免疫反应的因子,而且在包括神经系统在内的主要生理系统中具有许多关键作用。现在已知 IL-6 参与神经发生(影响神经元和神经胶质细胞),并参与成熟神经元和神经胶质细胞在正常条件下以及在广泛的损伤模型下的反应。在许多方面,IL-6 的行为类似于神经营养因子,并且似乎可以理解为什么它所属的细胞因子家族被称为神经细胞生成素。在几种主要的脑部疾病中,其表达受到影响,动物模型强烈表明 IL-6 可能在观察到的神经病理学中发挥作用,因此它是战略治疗的明确靶点。